Moderna said the FDA needs more time to assess the company's COVID-19 vaccine for use in adolescents aged 12 to 17, and may take until January to complete the review https://t.co/XQKOvBxoZU pic.twitter.com/N5Gt73gS8D— Reuters (@Reuters) November 1, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


